GlassScriptPhysician profile
Brian J Decastro
NPI 1114999851
$5,635.21
in general payments reported to CMS, 2019-2025
35 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $514 · 2021: $722 · 2022: $1,275 · 2023: $1,869 · 2024: $288 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Travel and Lodging: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,205.50 |
| Travel and Lodging | $1,127.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,925.61 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $525.39 | 2019-2022 | |
| Abbvie INC. | $369.14 | 2019-2023 | Botox |
| Janssen Biotech, INC. | $341.96 | 2019-2023 | Erleada |
| Pfizer INC. | $233.33 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $214.63 | 2019-2023 | Xiaflex |
| Urovant Sciences INC | $189.89 | 2021-2022 | |
| Urogen Pharma, INC. | $177.54 | 2020-2022 | |
| Teleflex LLC | $143.18 | 2022 | |
| Bioprotect Medical, INC. | $138.89 | 2024-2025 | Bioprotect Balloon Implant System |
| Antares Pharma, INC. | $136.01 | 2019-2023 | Tlando, Nocdurna, Xyosted |
| Acerus Pharmaceuticals Corporation | $133.10 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $121.60 | 2019-2021 | |
| Blue Earth Diagnostics | $116.70 | 2021-2024 | |
| Amgen INC. | $99.69 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $84.28 | 2019-2022 | |
| Olympus America INC. | $67.87 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $60.49 | 2023 | Bard Urinary Drainage Bag |
| Coloplast Corp | $55.16 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $54.94 | 2019 | |
| Myovant Sciences INC. | $52.13 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $50.20 | 2022-2023 | Prolaris |
| Melinta Therapeutics, LLC | $46.64 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $41.50 | 2022-2023 | Seglentis |
| Boston Scientific Corporation | $40.72 | 2019-2022 | |
| Clarus Therapeutics INC. | $32.72 | 2021 | |
| Axonics, INC. | $28.44 | 2022 | |
| Sumitomo Pharma America, INC. | $26.69 | 2023 | Orgovyx |
| Allergan, INC. | $23.99 | 2021 | |
| Genzyme Corporation | $23.92 | 2022 | |
| Tolmar, INC. | $19.82 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.48 | 2022 | |
| Convatec INC. | $15.73 | 2021 | |
| Merck Sharp & Dohme LLC | $14.29 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Decastro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.